A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus.

PubWeight™: 2.02‹?› | Rank: Top 2%

🔗 View Article (PMC 2234207)

Published in Proc Natl Acad Sci U S A on January 29, 2008

Authors

Samuel A Shelburne1, David Keith, Nicola Horstmann, Paul Sumby, Michael T Davenport, Edward A Graviss, Richard G Brennan, James M Musser

Author Affiliations

1: Departments of Medicine and Pathology, Baylor College of Medicine, Houston, TX 77030, USA.

Articles citing this

Streptococcus adherence and colonization. Microbiol Mol Biol Rev (2009) 2.83

Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A (2010) 2.43

Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog (2009) 1.87

Effect of a glucose impulse on the CcpA regulon in Staphylococcus aureus. BMC Microbiol (2009) 1.46

The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci. Trends Microbiol (2008) 1.38

Allostery in the LacI/GalR family: variations on a theme. Curr Opin Microbiol (2009) 1.37

The group A Streptococcus small regulatory RNA FasX enhances streptokinase activity by increasing the stability of the ska mRNA transcript. Mol Microbiol (2010) 1.37

Natural disruption of two regulatory networks in serotype M3 group A Streptococcus isolates contributes to the virulence factor profile of this hypervirulent serotype. Infect Immun (2014) 1.36

A genome-wide analysis of small regulatory RNAs in the human pathogen group A Streptococcus. PLoS One (2009) 1.36

CcpA-mediated repression of streptolysin S expression and virulence in the group A streptococcus. Infect Immun (2008) 1.32

A decade of molecular pathogenomic analysis of group A Streptococcus. J Clin Invest (2009) 1.30

The bacterial phosphoenolpyruvate:carbohydrate phosphotransferase system: regulation by protein phosphorylation and phosphorylation-dependent protein-protein interactions. Microbiol Mol Biol Rev (2014) 1.30

Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice. J Clin Invest (2011) 1.28

Gut microbial gene expression in mother-fed and formula-fed piglets. PLoS One (2010) 1.27

CcpA and LacD.1 affect temporal regulation of Streptococcus pyogenes virulence genes. Infect Immun (2009) 1.22

Extensive adaptive changes occur in the transcriptome of Streptococcus agalactiae (group B streptococcus) in response to incubation with human blood. PLoS One (2008) 1.19

CcpA ensures optimal metabolic fitness of Streptococcus pneumoniae. PLoS One (2011) 1.18

Multiple sugar: phosphotransferase system permeases participate in catabolite modification of gene expression in Streptococcus mutans. Mol Microbiol (2008) 1.10

A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection. PLoS Pathog (2010) 1.10

Host structural carbohydrate induces vector transmission of a bacterial plant pathogen. Proc Natl Acad Sci U S A (2009) 1.09

Seryl-phosphorylated HPr regulates CcpA-independent carbon catabolite repression in conjunction with PTS permeases in Streptococcus mutans. Mol Microbiol (2010) 1.08

Distinct single amino acid replacements in the control of virulence regulator protein differentially impact streptococcal pathogenesis. PLoS Pathog (2011) 1.07

Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc Natl Acad Sci U S A (2012) 1.07

Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol Microbiol (2008) 1.06

Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect Immun (2012) 1.05

Gene regulation by CcpA and catabolite repression explored by RNA-Seq in Streptococcus mutans. PLoS One (2013) 1.05

Maltose and maltodextrin utilization by Listeria monocytogenes depend on an inducible ABC transporter which is repressed by glucose. PLoS One (2010) 1.00

Glucose-dependent activation of Bacillus anthracis toxin gene expression and virulence requires the carbon catabolite protein CcpA. J Bacteriol (2010) 0.98

Surface export of GAPDH/SDH, a glycolytic enzyme, is essential for Streptococcus pyogenes virulence. MBio (2011) 0.96

PTS phosphorylation of Mga modulates regulon expression and virulence in the group A streptococcus. Mol Microbiol (2013) 0.96

Environmental acidification drives S. pyogenes pilus expression and microcolony formation on epithelial cells in a FCT-dependent manner. PLoS One (2010) 0.95

Carbohydrate availability regulates virulence gene expression in Streptococcus suis. PLoS One (2014) 0.94

Transcriptome adaptation of group B Streptococcus to growth in human amniotic fluid. PLoS One (2009) 0.94

Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature. PLoS One (2008) 0.94

The 4.5S RNA component of the signal recognition particle is required for group A Streptococcus virulence. Microbiology (2010) 0.93

Fueling the caries process: carbohydrate metabolism and gene regulation by Streptococcus mutans. J Oral Microbiol (2014) 0.93

Murine vaginal colonization model for investigating asymptomatic mucosal carriage of Streptococcus pyogenes. Infect Immun (2013) 0.92

Streptococcus pyogenes Ser/Thr kinase-regulated cell wall hydrolase is a cell division plane-recognizing and chain-forming virulence factor. J Biol Chem (2010) 0.92

Effect of starch and amylase on the expression of amylase-binding protein A in Streptococcus gordonii. Mol Oral Microbiol (2012) 0.90

A novel mode of regulation of the Staphylococcus aureus catabolite control protein A (CcpA) mediated by Stk1 protein phosphorylation. J Biol Chem (2012) 0.88

Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection. Appl Environ Microbiol (2012) 0.87

Effects of the ERES pathogenicity region regulator Ralp3 on Streptococcus pyogenes serotype M49 virulence factor expression. J Bacteriol (2012) 0.87

Adaptation of group A Streptococcus to human amniotic fluid. PLoS One (2010) 0.87

Role of Streptococcus intermedius DnaK chaperone system in stress tolerance and pathogenicity. Cell Stress Chaperones (2011) 0.86

Functional characterization of a newly identified group B Streptococcus pullulanase eliciting antibodies able to prevent alpha-glucans degradation. PLoS One (2008) 0.86

Structure and kinetic investigation of Streptococcus pyogenes family GH38 alpha-mannosidase. PLoS One (2010) 0.86

EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein. Biochem J (2013) 0.85

Molecular characterization and lytic activities of Streptococcus agalactiae bacteriophages and determination of lysogenic-strain features. J Bacteriol (2009) 0.85

Library screen identifies Enterococcus faecalis CcpA, the catabolite control protein A, as an effector of Ace, a collagen adhesion protein linked to virulence. J Bacteriol (2013) 0.85

Generation of metabolically diverse strains of Streptococcus pyogenes during survival in stationary phase. J Bacteriol (2009) 0.84

Transcriptional regulation of the capsular polysaccharide biosynthesis locus of streptococcus pneumoniae: a bioinformatic analysis. DNA Res (2009) 0.83

The phosphoenolpyruvate phosphotransferase system in group A Streptococcus acts to reduce streptolysin S activity and lesion severity during soft tissue infection. Infect Immun (2013) 0.83

Induction of a quorum sensing pathway by environmental signals enhances group A streptococcal resistance to lysozyme. Mol Microbiol (2015) 0.83

HP0197 contributes to CPS synthesis and the virulence of Streptococcus suis via CcpA. PLoS One (2012) 0.82

Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius. Infect Immun (2010) 0.82

Distinct time-resolved roles for two catabolite-sensing pathways during Streptococcus pyogenes infection. Infect Immun (2010) 0.82

Comparative proteomic analyses of Streptococcus suis serotype 2 cell wall-associated proteins. Curr Microbiol (2010) 0.82

Insights from the genome sequence of a Salmonella enterica serovar Typhi strain associated with a sporadic case of typhoid fever in Malaysia. J Bacteriol (2012) 0.81

Regulation and consequence of serine catabolism in Streptococcus pyogenes. J Bacteriol (2011) 0.81

Intracellular Streptococcus pyogenes in human macrophages display an altered gene expression profile. PLoS One (2012) 0.81

A comparative genomics, network-based approach to understanding virulence in Vibrio cholerae. J Bacteriol (2009) 0.80

Niche-specific contribution to streptococcal virulence of a MalR-regulated carbohydrate binding protein. Mol Microbiol (2011) 0.80

CcpA is important for growth and virulence of Enterococcus faecium. Infect Immun (2014) 0.79

The fruRBA Operon Is Necessary for Group A Streptococcal Growth in Fructose and for Resistance to Neutrophil Killing during Growth in Whole Human Blood. Infect Immun (2016) 0.79

CcpA-dependent carbohydrate catabolite repression regulates galactose metabolism in Streptococcus oligofermentans. J Bacteriol (2012) 0.79

Differential virulence gene expression of group A Streptococcus serotype M3 in response to co-culture with Moraxella catarrhalis. PLoS One (2013) 0.79

Hyaluronic acid derived from other streptococci supports Streptococcus pneumoniae in vitro biofilm formation. Biomed Res Int (2013) 0.79

Streptolysin S of Streptococcus anginosus exhibits broad-range hemolytic activity. Med Microbiol Immunol (2014) 0.78

LacR mutations are frequently observed in Streptococcus intermedius and are responsible for increased intermedilysin production and virulence. Infect Immun (2013) 0.78

Analysis of growth-phase regulated genes in Streptococcus agalactiae by global transcript profiling. BMC Microbiol (2009) 0.78

Identification of an unusual pattern of global gene expression in group B Streptococcus grown in human blood. PLoS One (2009) 0.77

Regulatory gene mutation: A driving force behind group A Streptococcus strain- and serotype-specific variation. Mol Microbiol (2016) 0.75

A PTS EII mutant library in Group A Streptococcus identifies a promiscuous man-family PTS transporter influencing SLS-mediated hemolysis. Mol Microbiol (2016) 0.75

A Multi-Serotype Approach Clarifies the Catabolite Control Protein A Regulon in the Major Human Pathogen Group A Streptococcus. Sci Rep (2016) 0.75

Stress Physiology of Lactic Acid Bacteria. Microbiol Mol Biol Rev (2016) 0.75

Filamentous fungal carbon catabolite repression supports metabolic plasticity and stress responses essential for disease progression. PLoS Pathog (2017) 0.75

The Collagen Binding Proteins of Streptococcus mutans and Related Streptococci. Mol Oral Microbiol (2016) 0.75

Identification and characterization of a novel secreted glycosidase with multiple glycosidase activities in Streptococcus intermedius. J Bacteriol (2014) 0.75

A Flexible Binding Site Architecture Provides New Insights into CcpA Global Regulation in Gram-Positive Bacteria. MBio (2017) 0.75

Use of a Phosphorylation Site Mutant to Identify Distinct Modes of Gene Repression by the Control of Virulence Regulator (CovR) in Streptococcus pyogenes. J Bacteriol (2017) 0.75

Detection of influent virulence and resistance genes in microarray data through quasi likelihood modeling. Mol Genet Genomics (2013) 0.75

Articles cited by this

How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol Mol Biol Rev (2006) 6.39

Catabolite repression of alpha-amylase gene expression in Bacillus subtilis involves a trans-acting gene product homologous to the Escherichia coli lacl and galR repressors. Mol Microbiol (1991) 4.04

Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis (2005) 3.89

Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog (2006) 3.68

Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A (1991) 3.60

Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol (2003) 3.04

Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci U S A (2005) 2.84

Control of key metabolic intersections in Bacillus subtilis. Nat Rev Microbiol (2007) 2.81

Genetic locus for streptolysin S production by group A streptococcus. Infect Immun (2000) 2.52

Catabolite repression mediated by the CcpA protein in Bacillus subtilis: novel modes of regulation revealed by whole-genome analyses. Mol Microbiol (2001) 2.51

Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci U S A (2005) 2.45

EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J (2001) 2.38

Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Mol Endocrinol (1996) 2.36

CcpA-dependent carbon catabolite repression in bacteria. Microbiol Mol Biol Rev (2003) 2.21

Catabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniae. J Bacteriol (2005) 2.09

Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance. Antimicrob Agents Chemother (2006) 1.99

Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S. J Infect Dis (2005) 1.92

Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol Microbiol (2004) 1.92

Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol (2005) 1.86

Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection. Infect Immun (2005) 1.78

Role of RegM, a homologue of the catabolite repressor protein CcpA, in the virulence of Streptococcus pneumoniae. Infect Immun (2002) 1.74

Linking the nutritional status of Streptococcus pyogenes to alteration of transcriptional gene expression: the action of CodY and RelA. Int J Med Microbiol (2006) 1.72

Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences. Proc Natl Acad Sci U S A (2006) 1.59

Structural basis for allosteric control of the transcription regulator CcpA by the phosphoprotein HPr-Ser46-P. Cell (2004) 1.58

Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol Microbiol (2007) 1.51

Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx. Infect Immun (2006) 1.42

New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol (2007) 1.41

Sucrose metabolism contributes to in vivo fitness of Streptococcus pneumoniae. Mol Microbiol (2007) 1.39

The CcpA protein is necessary for efficient sporulation and enterotoxin gene (cpe) regulation in Clostridium perfringens. J Bacteriol (2004) 1.38

Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Infect Immun (2005) 1.37

A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. EMBO J (2006) 1.35

Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A (2005) 1.33

Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group a streptococcus. Infect Immun (2006) 1.22

Structural basis for the metal-selective activation of the manganese transport regulator of Bacillus subtilis. Biochemistry (2006) 1.14

Articles by these authors

STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99

Hfq: a bacterial Sm-like protein that mediates RNA-RNA interaction. Mol Cell (2002) 5.26

Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol (2005) 5.18

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS (2005) 5.08

Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A (2002) 5.07

Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A (2002) 4.85

spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol (2004) 4.80

Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A (2008) 4.38

Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics (2002) 4.11

Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis (2005) 3.89

Structures of the pleiotropic translational regulator Hfq and an Hfq-RNA complex: a bacterial Sm-like protein. EMBO J (2002) 3.88

Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci U S A (2002) 3.83

Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog (2006) 3.68

Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A (2006) 3.33

Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect Dis (2005) 3.32

Structure of Escherichia coli Hfq bound to polyriboadenylate RNA. Proc Natl Acad Sci U S A (2009) 3.04

Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci U S A (2005) 2.84

Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science (2009) 2.74

Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2003) 2.71

Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63

Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med (2012) 2.62

Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A (2014) 2.56

Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A (2003) 2.54

Structural basis for cooperative DNA binding by two dimers of the multidrug-binding protein QacR. EMBO J (2002) 2.53

Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis (2003) 2.50

Computational analysis of bacterial RNA-Seq data. Nucleic Acids Res (2013) 2.50

Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci U S A (2005) 2.45

Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis (2005) 2.45

Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A (2010) 2.43

Structure of an OhrR-ohrA operator complex reveals the DNA binding mechanism of the MarR family. Mol Cell (2005) 2.41

Molecular correlates of host specialization in Staphylococcus aureus. PLoS One (2007) 2.41

Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2006) 2.34

Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr (2003) 2.33

Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A (2004) 2.32

Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med (2014) 2.29

Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J Infect Dis (2004) 2.29

The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol (2002) 2.27

Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS One (2007) 2.22

In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J Bacteriol (2002) 2.19

Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med (2012) 2.14

Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival. Infect Immun (2002) 2.10

Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol (2005) 2.05

Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007. Emerg Infect Dis (2014) 2.03

Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol (2007) 2.01

Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (2003) 1.99

Prokaryotic transcription regulators: more than just the helix-turn-helix motif. Curr Opin Struct Biol (2002) 1.94

Characterization of the Manila family of Mycobacterium tuberculosis. J Clin Microbiol (2003) 1.89

Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One (2007) 1.89

Portable, battery-operated, low-cost, bright field and fluorescence microscope. PLoS One (2010) 1.88

Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response. Arch Pathol Lab Med (2011) 1.83

Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data. J Biol Chem (2003) 1.81

Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenes. Infect Immun (2002) 1.79

Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect Immun (2002) 1.78

Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. J Infect Dis (2004) 1.75

Structure of FitAB from Neisseria gonorrhoeae bound to DNA reveals a tetramer of toxin-antitoxin heterodimers containing pin domains and ribbon-helix-helix motifs. J Biol Chem (2006) 1.71

Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A (2011) 1.70

rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol (2006) 1.68

Identification and characterization of HtsA, a second heme-binding protein made by Streptococcus pyogenes. Infect Immun (2003) 1.68

Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. J Infect Dis (2003) 1.68

An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J Leukoc Biol (2003) 1.66

Correlation of acetate catabolism and growth yield in Staphylococcus aureus: implications for host-pathogen interactions. Infect Immun (2003) 1.66

Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun (2010) 1.62

CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun (2009) 1.62

Risk factors for renal cell carcinoma in the VITAL study. J Urol (2013) 1.62

Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol (2008) 1.62

Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol (2003) 1.59

Structural mechanisms of multidrug recognition and regulation by bacterial multidrug transcription factors. Mol Microbiol (2002) 1.59

Structural basis for allosteric control of the transcription regulator CcpA by the phosphoprotein HPr-Ser46-P. Cell (2004) 1.58

Structural mechanism of organic hydroperoxide induction of the transcription regulator OhrR. Mol Cell (2007) 1.58

Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315. Infect Immun (2003) 1.57

Molecular pathogenesis of necrotizing fasciitis. Annu Rev Pathol (2010) 1.56

The agr radiation: an early event in the evolution of staphylococci. J Bacteriol (2005) 1.55

A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun (2008) 1.54

Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am J Pathol (2006) 1.53

Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect Immun (2003) 1.53

Genome diversification in Staphylococcus aureus: Molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins. Infect Immun (2003) 1.53

Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis (2006) 1.52

M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol (2002) 1.51

Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study. Lancet Infect Dis (2013) 1.50

Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes. J Bacteriol (2003) 1.50

Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J Clin Microbiol (2007) 1.49

Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One (2008) 1.49

Epidemiology of tuberculosis in young children in the United States. Pediatrics (2014) 1.49

Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus. J Infect Dis (2003) 1.49

Streptococcus mitis strains causing severe clinical disease in cancer patients. Emerg Infect Dis (2014) 1.47

Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A (2010) 1.47

Structural mechanism of the simultaneous binding of two drugs to a multidrug-binding protein. EMBO J (2004) 1.47

Men who seek infertility care may not represent the general U.S. population: data from the National Survey of Family Growth. Urology (2011) 1.47